| Issue |
Title |
| Vol 16, No 3 (2014) |
Avastin in clinical chemotherapy of malignant tumors |
|
|
Gorbunova V.A. |
| Vol 21, No 1 (2019) |
HPV-associated lesions in the Russian Federation: assessment of the problem |
|
|
Briko N.I., Lopukhov P.D., Kaprin A.D., Novikova E.G., Trushina O.I., Khaldin A.A., Isaeva D.R., Skvortsova A.I. |
| Vol 21, No 4 (2019) |
The role of a multidisciplinary approach in the treatment of hepatocellular carcinoma |
|
|
Kit O.I., Vladimirova L.I., Storozhakova A.E., Snezhko T.A., Kalabanova E.A., Samaneva N.I., Svetitskaia I.V., Kabanov S.N. |
| Vol 22, No 1 (2020) |
Modern view on the issues of diagnosis and verification of axillary lymph nodes involvement in early breast cancer |
|
|
Kolyadina I.V., Danzanova T.Y., Khokhlova S.V., Trofimova O.P., Kovaleva E.V., Rodionov V.V., Poddubnaya I.V. |
| Vol 22, No 1 (2020) |
The efficacy of the combination of eribulin and trastuzumab in advanced HER2-positive breast cancer: the results of Russian observational study |
|
|
Kovalenko E.I., Artamonova E.V., Karabina E.V., Andreiashkina I.I., Prokof’eva E.A., Popova N.O., Gaisina E.A., Evstigneeva I.V., Shaidorov M.V., Zhiliaeva L.A., Ponomarenko D.M., Khasanova A.I., Mukhametshina G.Z., Koziakov A.E., Vorotilina L.V., Povyshev A.I., Simolina E.I., Marfutov V.V., Kozlov D.V., Suslova I.R., Shikina V.E., Karandeeva T.V., Shepel’ A.O., Kramskaia L.V., Oskirko D.A., Frolova O.S. |
| Vol 17, No 4 (2015) |
The ability to combine autodermoplasty in the treatment of patients with malignant tumors of the skin extremities (clinical observation) |
|
|
Vaschenko L.N., Dashkova I.R., Kechedzhieva E.E., Babieva S.M. |
| Vol 19, No 1 (2017) |
The role of bevacizumab in the treatment of patients with ovarian and cervical cancer |
|
|
Khokhlova S.V. |
| Vol 21, No 1 (2019) |
The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review) |
|
|
Morozov D.A., Kolyadina I.V., Poddubnaya I.V., Chumakov P.M., Ilinskaya G.V., Bokhian V.Y., Sopova M.I. |
| Vol 11, No 3 (2009) |
Mesto tsetuksimaba v terapii metastaticheskogo raka tolstoy kishki |
|
|
Artamonova E.V. |
| Vol 21, No 3 (2019) |
Osimertinib for the first-line treatment of EGFR-positive non-small cell lung cancer |
|
|
Reutova E.V., Laktionov K.P., Iudin D.I., Neliubina L.A., Gorokhova G.K., Egorova A.V. |
| Vol 16, No 1 (2014) |
Clinical cases of treatment of hepatocellular carcinoma |
|
|
Lazarev S.A., Mamontov K.G., Manihas G.M., Antimonik N.Y. |
| Vol 17, No 1 (2015) |
A population-based portrait of breast cancer in russia: a cancer register-based analysis in russian |
|
|
Poddubnaya I.V., Kolyadina I.V., Kalashnikov N.D., Borisov D.A., Makarova M.V. |
| Vol 11, No 2 (2009) |
Neksavar® (sorafenib)v lechenii rasprostranennogo pochechno-kletochnogo raka |
|
|
Podregul'skiy K.E. |
| Vol 21, No 3 (2019) |
Modern ultrasound technologies in monitoring the effectiveness of chemotherapy for cervical cancer |
|
|
Musaeva Z.R., Chekalova M.A., Mesheryakov A.A. |
| Vol 17, No 3 (2015) |
Adenosquamous carcinoma of the colon: case report |
|
|
Nefedova N.A., Kharlova O.A., Malkov P.G., Kharlov N.S., Danilova N.V. |
| Vol 11, No 2 (2009) |
Lechenie metastazov kolorektal'nogo raka v pecheni |
|
|
Patyutko Y.I., Sagaydak I.V., Pylev A.L., Podluzhnyy A.N., Chuchuev E.S., Shishkina N.A. |
| Vol 10, No 4 (2008) |
Tsetuksimab pri lechenii metastaticheskogo kolorektal'nogo raka |
|
|
Sekacheva M.I., Skipenko O.G. |
| Vol 11, No 4 (2009) |
Denosumab (AMG-162) v profilaktike osteoporoza, vyzvannogo priemom ingibitorov aromatazy u bol'nykh rakom molochnoy zhelezy v ad\"yuvantnoy terapii i u bol'nykh rakom predstatel'noy zhelezy pri polnoy androgennoy blokade |
|
|
Lichinitser M.R., Semenov N.N. |
| Vol 18, No 2 (2016) |
Passive smoking prevalence among patients of krasnoyarsk regional oncologic dispensary |
|
|
Kutumova O.Y., Kononova L.I., Dobretsova E.A., Shulmin A.B., Korotkova K.M., Rossiyeva T.V. |
| Vol 19, No 2 (2017) |
PARP inhibitors in female reproductive system cancers |
|
|
Pokataev I.A., Tyulyandin S.A. |
| Vol 17, No 1 (2015) |
The role of targeted therapy in the treatment of advanced hepatocellular carcinoma |
|
|
Shakhnovich E.B., Kerbikov O.B., Kulaga E.A. |
| Vol 18, No 2 (2016) |
Supportive therapy for ovarian cancer |
|
|
Pokataev I.A., Tyulyandin S.A. |
| Vol 15, No 1 (2013) |
Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies |
|
|
Kit O.I., Vladimirova L.Y., Sholokhova E.A. |
| Vol 19, No 1 (2017) |
Anxiety and cognitive impairment in elderly patients with gastrointestinal cancers |
|
|
Stilidi I.S., Kotyukova A.Y., Lyadov V.K. |
| Vol 18, No 1 (2016) |
Klinicheskie sluchai lecheniya gepatotsellyulyarnogo raka v Rossii. Klinicheskiy sluchay 1 Bolee chem 3-letnyaya stabilizatsiya protsessa gepatotsellyulyarnogo raka na fone dlitel'nogo priema preparata sorafenib |
|
|
Sheko S.S., Dem'yanova G.A. |
| Vol 8, No 1 (2006) |
Fraksiparin kak osnovnoe sredstvo profilaktiki tromboembolii legochnoy arterii v posleoperatsionnom periode u bol'nykh kolorektal'nym rakom |
|
|
Makarov O.G. |
| Vol 16, No 3 (2014) |
Current algorhytm of screening and early diagnosis of hepatocellular carcinoma |
|
|
Tikhonov I.N., Pavlov C.S., Mayevskaya M.V., Ivashkin V.T. |
| Vol 18, No 2 (2016) |
Second primary cancer in patients with head and neck squamous cell carcinoma: case report |
|
|
Agabekyan G.O., Stelmakh D.K., Aydarbekova A.A. |
| Vol 10, No 2 (2008) |
Primenenie tsetuksimaba v lechenii ploskokletochnogo raka golovy i shei |
|
|
Romanov I.S., Kupchan D.Z. |
| Vol 11, No 3 (2009) |
Targetnaya terapiya rasprostranennogo raka pochki: problema vybora preparata na primere mul'tikinaznykh ingibitorov |
|
|
Matveev V.B. |
| Vol 7, No 2 (2005) |
Estramustina fosfat (estratsit) v lechenii raka predstatel'noy zhelezy (po materialam Journal of Clinical Oncology, 2005 ASCO Proceedings) |
|
|
Podregul'skiy K.E. |
| Vol 20, No 3 (2018) |
Clinical prognostic factors of bilateral synchronous renal cancer |
|
|
Komarov M.I., Matveev V.B., Volkova M.I., Komarov I.G., Ridin V.A. |
| Vol 19, No 3 (2017) |
Regorafenib: from clinical research to clinical practice |
|
|
Fedyanin M.Y., Tryakin A.A. |
| Vol 8, No 1 (2006) |
Keliks (pegilirovannyy liposomal'nyy doksorubitsin) v programmnoy terapii 2-y linii metastaticheskogo raka molochnoy zhelezy |
|
| Vol 20, No 2 (2018) |
The post-mastectomy syndrome: the secondary lympedema after the combined treatment of breast cancer (the literature review and own results) |
|
|
Stepanova A.M., Merzlyakova A.M., Khulamhanova M.M., Trofimova O.P. |
| Vol 18, No 1 (2016) |
Systemic drug therapy of metastatic pancreatic cancer |
|
|
Pokataev I.A., Tyulyandin S.A. |
| Vol 16, No 2 (2014) |
Successful treatment with sorafenib in patients with advanced hepatocellular carcinoma: clinical case |
|
|
Bisovskaya Y.V., Breder V.V., Medvedeva B.M., Gorbunova V.A. |
| Vol 15, No 4 (2013) |
The ways of erlotinib resistance overcoming in treatment of patients with eGFr mutated nsClC |
|
|
Orlov S.V. |
| Vol 11, No 3 (2009) |
Taktika vedeniya bol'nogo metastaticheskim kolorektal'nym rakom s izolirovannymi metastazami v pechen' |
|
|
Tryakin A.A. |
| Vol 9, No 3 (2007) |
Fulvestrant v sovremennoy terapii rasprostranennogo raka molochnoy zhelezy: farmakoekonomicheskoe obosnovanie |
|
|
Komarova V.P., Komarova L.E., Poddubnaya I.V. |
| Vol 8, No 2 (2006) |
Sovremennye vozmozhnosti lecheniya kolorektal'nogo raka |
|
|
Barsukov Y.A., Knysh V.I. |
| Vol 19, No 3 (2017) |
Dynamics of circulating tumor cells during neoadjuvant chemotherapy in patients with locally-advanced breast cancer |
|
|
Nenakhova Y.N., Lyadov V.K., Poddubnaya I.V. |
| Vol 18, No 3 (2016) |
Modern therapy of radioactive iodine-refractory differentiated thyroid cancer: resolution of the Expert Council |
|
|
Rumyantsev P.O., Gorbunova V.A., Podvyaznikov S.O., Zhukov N.V., Isaev P.A., Krylov V.V., Mudunov A.M., Rodichev A.A., Shavarova E.K. |
| Vol 17, No 4 (2015) |
Neoadjuvant systemic therapy of HER2-positive breast cancer |
|
|
Frolova M.A. |
| Vol 16, No 3 (2014) |
Experience of eribulin application in previously treated patients with metastatic or locally recurrent breast cancer under the clinical trial |
|
|
Ahmetzanov F.S., Ahmetzanova F.F. |
| Vol 15, No 2 (2013) |
Results of preoperative antitumor therapy in combination with bevacizumab and KRAS status during liver resections for colorectal cancer metastases |
|
|
Sekacheva M.I., Bagmet N.N., Polishchuk L.O., Glazova O.V., Zaklyazminskaya E.V., Skripenko O.G. |
| Vol 11, No 1 (2009) |
Problemy endokrinoterapii raka molochnoy zhelezy u muzhchin |
|
|
Borisova E.I., Voronina I.Y., Gutorov S.L. |
| Vol 9, No 1 (2007) |
Melkokletochnyy rak legkogo: chto izmenilos' za poslednie 30 let? |
|
|
Bychkov M.B. |
| Vol 7, No 3 (2005) |
Znachimost' khromoskopii, endosonografii i uvelichitel'noy endoskopii v reshenii diagnosticheskikh problem predopukholevoy patologii i rannego raka zheludochno-kishechnogo trakta |
|
|
Poddubnyy B.K., Kuvshinov Y.P., Malikhova O.A., Frolova I.P. |
| Vol 20, No 4 (2018) |
Non-small cell lung cancer with the tracheal bifurcation involvement. Carinal pneumonectomy or chemo-radiation therapy? |
|
|
Dadyev I.A., Davydov M.M., Shogenov M.S., Abdullaev A.G., Ibraev M.A., Filatov A.A. |
| Vol 19, No 2 (2017) |
Brachytherapy with ultrasound assistance in patients with cervical cancer |
|
|
Kizhaev Y.E., Razumova E.L., Bessolova O.V. |
| Vol 18, No 3 (2016) |
The results of epidemiological screening program of HER2 status in patients with breast cancer in the federal districts of the Russian Federation in 2015 |
|
|
Poddubnaya I.V., Frank G.A., Yagudina R.I., Koroleva N.I., Zavalishina L.E. |
| Vol 17, No 2 (2015) |
Liver transplantation for hepatocellular carcinoma |
|
|
Khubutiya M.S., Novruzbekov M.S., Olisov O.D., Galankina I.E., Zimina L.N. |
| Vol 16, No 2 (2014) |
Press-release. «Merck Serono» announces new retrospective analysis shows significant clinical benefit in overall survival for metastatic colorectal cancer patients with RAS wild-type tumors receiving Erbitux® plus FOLFIRI |
|
| Vol 11, No 4 (2009) |
Tartseva (erlotinib) v terapii rasprostranennoy adenokartsinomy legkogo pri nalichii mutatsii retseptora epidermal'nogo faktora rosta |
|
|
Orlov S.V., Dvorakovskaya I.V., Mosin I.V., Stel'makh L.V., Gorokhov A.A., Martynenko O.N., Poltoratskiy A.N. |
| Vol 10, No 1 (2008) |
Predvaritel'nye rezul'taty induktsionnoy khimioterapii s paklitakselom pri mestnorasprostranennom rake sheyki matki |
|
|
Morkhov K.Y., Kuznetsov V.V., Lebedev A.I., Nechushkina V.M., Zakharova T.I., Tyulyandin S.A. |
| Vol 8, No 1 (2006) |
Opyt primeneniya Taksotera v kombinatsii s doksorubitsinom v kachestve khimioterapii 1-y linii u bol'nykh metastaticheskim rakom molochnoy zhelezy |
|
|
Samoylenko V.M., Gorbunova V.A., Koshelev M.N., Yurashko K.V. |
| Vol 7, No 1 (2005) |
Faktory prognoza pri rake molochnoy zhelezy |
|
|
Bozhok A.A., Semiglazov V.F., Semiglazov V.V., Arzumanov A.S., Kletsel' A.E. |
| Vol 20, No 2 (2018) |
The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan |
|
|
Berdimyradova M.B., Khadjiev S.M., Khommadova D.N., Polatova G.O., Kakajanova A.O., Batyrov C.B., Penayev D.N., Agayeva B.G., Annaberdiyeva G.A. |
| Vol 19, No 1 (2017) |
The characteristics of determination of BRCA1 and BRCA2 mutations in serous ovarian cancer |
|
|
Demidova I.A. |
| Vol 17, No 3 (2015) |
Efficacy of cisplatin-based combinations in chemoradiation therapy of cervical cancer |
|
|
Bazaeva I.Y., Gorbounova V.A., Kravets O.A., Khokhlova S.V., Romanova E.A. |
| Vol 16, No 4 (2014) |
Male breast cancer: review of the literature |
|
|
Nikolaev K.S., Semiglazov V.F., Semiglazov V.V. |
| Vol 15, No 3 (2013) |
Retseptor faktora rosta fibroblastov 1-go tipa kak mishen' tselenapravlennoy terapii pochechno-kletochnogo raka |
|
|
Timofeev I.V. |
| Vol 9, No 3 (2007) |
Postmastektomicheskaya limfedema verkhnikh konechnostey: vozmozhnosti konservativnogo lecheniya |
|
|
Myasnikova M.O. |
| Vol 8, No 2 (2006) |
Sostoyanie zabolevaemosti, smertnosti i onkologicheskoy pomoshchi pri zlokachestvennykh novoobrazovaniyakh kozhi v Navoiyskoy oblasti Respubliki Uzbekistan |
|
|
Kudryavtsev I.Y., Aksel' E.M., Kerimov R.A. |
| Vol 19, No 4 (2017) |
Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case |
|
|
Kolyadina I.V., Ganshina I.P., Zhukova L.G., Abdullaev A.G., Andreeva Y.Y., Danzanova T.Y., Sinyukova G.T., Komov D.V., Kozlov N.A., Filonenko D.A., Gordeeva O.O., Lubennikova E.V. |
| Vol 18, No 2 (2016) |
Predictive biomarkers in chemotherapy of pancreatic duct adenocarcinoma: rewiew of the literature |
|
|
Kovalenko Z.A., Kekeeva T.V., Lyadov V.K. |
| Vol 17, No 4 (2015) |
Modern possibilities of targeted therapy in metastatic colorectal cancer |
|
|
Gorbunova V.A. |
| Vol 15, No 3 (2013) |
Prolongirovannaya blokada angiogeneza pri metastaticheskom kolorektal'nom rake (novye dannye) |
|
|
Artamonova E.V. |
| Vol 11, No 1 (2009) |
Rol' i mesto tsetuksimaba v 1-y linii terapii metastaticheskogo kolorektal'nogo raka |
|
|
Kopp M.V., Koroleva I.A. |
| Vol 9, No 1 (2007) |
Antiestrogennaya terapiya pri rake molochnoy zhelezy. Naskol'ko bezopasny ingibitory aromatazy? |
|
|
Ptushkin V.V. |
| Vol 7, No 2 (2005) |
Farmorubitsin v klinicheskoy praktike |
|
|
Gorbunova V.A. |
| Vol 20, No 3 (2018) |
Vliyanie na prognoz estrogenovykh retseptorov a v opukholevykh kletkakh u patsientov, radikal'no operirovannykh po povodu nemelkokletochnogo raka legkogo |
|
|
Novikov D.V., Polotskiy B.E., Bogush T.A., Davidov M.M., Ahmedov B.B., Rotobelskaya L.E. |
| Vol 19, No 3 (2017) |
Olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer |
|
|
Khokhlova S.V. |
| Vol 18, No 2 (2016) |
Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype |
|
|
Karabina E.V., Zhukova L.G. |
| Vol 16, No 1 (2014) |
The role of tamoxifen in the therapy of metastatic ovarian cancer |
|
|
Davidenko I.S., Kazantseva M.V., Porhanova N.V., Ohanyan M.R. |
| Vol 11, No 4 (2009) |
Aromazin v ad\"yuvantnoy terapii raka molochnoy zhelezy |
|
|
Artamonova E.V. |
| Vol 9, No 4 (2007) |
Molekulyarno-biologicheskie markery v khimioterapevticheskom lechenii metastaticheskogo kolorektal'nogo raka |
|
|
Kuznetsova E.A., Eropkin P.V., Kashnikov V.N. |
| Vol 8, No 3 (2006) |
Faktory prognoza v opredelenii ob\"ema operatsii pri differentsirovannom rake shchitovidnoy zhelezy |
|
|
Brzhezovskiy V.Z., Lyubaev V.L., Kochurina G.Y., Subramanian S. |
| Vol 5, No 2 (2003) |
Sovremennye standarty lecheniya raka yaichnikov |
|
|
Kharitonova T.V. |
| Vol 20, No 2 (2018) |
Ribociclib in 1st line HR+ breast cancer treatment |
|
|
Zhukova L.G., Ganshina I.P., Gordeeva O.O., Lubennikova E.V. |
| Vol 19, No 1 (2017) |
Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer |
|
|
Pavlikova O.A., Kolyadina I.V., Komov D.V., Vishnevskaya Y.V., Poddubnaya I.V. |
| Vol 17, No 3 (2015) |
Latent herpes virus infection in the carcinogenesis of bladder cancer |
|
|
Loran O.B., Sinyakova L.A., Gundorova L.V., Kosov V.A., Kosova I.V., Kolbasov D.N., Kononkov I.V. |
| Vol 16, No 2 (2014) |
Pharmacoeconomic usefulness of the drug Giotrif® (afatinib) in first-line treatment of locally advanced or metastatic non-small cell lung cancer with a mutation of epidermal growth factor receptor (EGFR) |
|
|
Kolbin A.S., Kurylev A.A., Pavlysh A.V., Proskurin M.A., Balykina Y.Y. |
| Vol 15, No 4 (2013) |
The efficiency of trabectedin in the monotherapy and combinations in the treatment of advanced ovarian cancer |
|
|
Cherkasova M.V., Khokhlova S.V., Limareva S.V., Bazaeva I.Y., Orel N.F., Gorbunova V.A., Poddubnaya I.V. |
| Vol 9, No 2 (2007) |
Sravnitel'noe issledovanie opredeleniya NER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii |
|
|
Zavalishina L.E., Andreeva Y.Y., Ryazantseva A.A., Bateva M.V., Frank G.A. |
| Vol 7, No 3 (2005) |
Sovremennye vozmozhnosti lekarstvennoy terapii operabel'nogo raka molochnoy zhelezy (po materialam St. Gallen, 2005) |
|
|
Letyagin V.P., Vysotskaya I.V. |
| Vol 21, No 1 (2019) |
Opportunities of the pharmacogenetic approach to personalized tamoxifen breast cancer therapy: case reports |
|
|
Savelyeva M.I., Dudina I.A., Zaharenkova J.S., Ignatova A.K., Ryzhikova K.A., Sozaeva Z.A., Kudlay D.A., Perfileva O.M., Poddubnaya I.V. |
| Vol 19, No 3 (2017) |
Irreversible electroporation of locally advanced unresectable pancreatic cancer |
|
|
Patyutko Y.I., Polyakov A.N., Kudashkin N.E., Podluzhnyi D.V., Chistyakova O.V. |
| Vol 18, No 2 (2016) |
Long-term treatment of neuroendocrine tumor of the pancreas |
|
|
Khvastunov R.A., Egorov S.V., Kargin A.V., Kim A.Y. |
| Vol 17, No 2 (2015) |
Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemotherapy |
|
|
Krivorotko P.V., Burdaeva O.N., Nechaeva M.N., Frolova M.A., Kopp M.V., Abrosimova A.A., Ivanov R.A. |
| Vol 16, No 2 (2014) |
Algorithm of treatment of patients with castrate-resistant prostate cancer: modern concept and perspectives |
|
|
Alekseev B.Y., Nyushko K.M., Kalpinskiy A.S., Kaprin A.D. |
| Vol 15, No 2 (2013) |
The concept of resectability in the treatment of colorectal cancer liver metastases: the present notion |
|
|
Bagmet N.N., Bedzhanyan A.L., Polishchuk L.O., Sekacheva M.I., Shatveryan G.A., Skipenko O.G. |
| Vol 11, No 1 (2009) |
Bevatsizumab (Avastin) v kombinatsii s taksanami v 1-y linii lecheniya HER-2-negativnogo metastaticheskogo raka molochnoy zhelezy(Rezul'taty issledovaniya AVADO) |
|
|
Zhukova L.G. |
| Vol 9, No 1 (2007) |
Immunogistokhimicheskoe opredelenie ekspressii HER2/neu pri rake molochnoy zhelezy (po dannym Smolenskogo oblastnogo onkologicheskogo klinicheskogo dispansera) |
|
|
Shisterova O.A., Golik E.P. |
| Vol 7, No 2 (2005) |
Aromazin (ekzemestan) v neoad\"yuvantnoy i ad\"yuvantnoy gormonoterapii raka molochnoy zhelezy |
|
|
Makarenko N.P. |
| Vol 20, No 4 (2018) |
A method of laparoscopic installation of port systems for intra-abdominal chemotherapy in patients with advanced ovarian cancer |
|
|
Lozovaya V.V., Cherkes L.V., Malikhova O.A., Poddubny B.K. |
| Vol 19, No 2 (2017) |
Perspectives of pharmacogenetics approach to personalized tamoxifen therapy |
|
|
Savelyeva M.I., Ignatova A.K., Panchenko Y.S., Urvantseva I.A., Poddubnaya I.V. |
| Vol 18, No 2 (2016) |
New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer |
|
|
Semiglazova T.Y., Klyuge V.A., Semiglazov V.V., Teletaeva G.M., Krivorotko P.V., Dashyan G.A., Paltuev R.M., Tkachenko E.V., Donskikh R.V., Semiglazov V.F. |
| Vol 16, No 3 (2014) |
Clinical experience with abiraterone acetate application in patients with castration-resistant prostate cancer |
|
|
Gridneva Y.V., Matveev V.B., Kupchan D.Z., Kalinin S.A., Peters M.V. |
| 1 - 100 of 280 Items |
1 2 3 > >> |
